Short Interest in Starpharma Holdings Limited (OTCMKTS:SPHRY) Drops By 14.8%

Starpharma Holdings Limited (OTCMKTS:SPHRYGet Free Report) was the target of a large drop in short interest in the month of April. As of April 30th, there was short interest totalling 2,300 shares, a drop of 14.8% from the April 15th total of 2,700 shares. Based on an average daily volume of 2,200 shares, the short-interest ratio is currently 1.0 days.

Starpharma Price Performance

Shares of SPHRY stock opened at $0.72 on Tuesday. The company’s 50 day moving average is $0.85 and its 200 day moving average is $0.94. Starpharma has a 52-week low of $0.72 and a 52-week high of $3.04.

About Starpharma

(Get Free Report)

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.

Further Reading

Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.